Needle-free injection devices
As a spin-out from Oxford University, Oxford BioSciences (later Powderject) came to Kinneir Dufort for assistance in translating their novel pan-dermal (needle-less syringe) technology into usable, manufacturable and cost-effective designs for a variety of clinical applications.
Working in close liaison with Powderject we developed and prototyped the internal mechanisms, the design for assembly and the external look, feel and usability for an entire range of pan-dermal drug delivery devices. Our Looks-Like Works-Like prototypes, made in quantities up to several hundred, were vitally important in enabling Powderject to present and demonstrate their technology to the media and to investors globally.
With the help of Kinneir Dufort’s rigorous design input and high quality prototypes Powderject rapidly achieved a strong business platform, generating intense media interest and investment funding, leading to a focus on the vaccines sector and the acquisition by US vaccines company Chiron for £542M.
As needle-free technologies developed, the dry powder based system found particular application in the area of DNA vaccines. Now acquired by Pfizer, the needle-free injector systems envisioned by Kinneir Dufort with the pioneering team at Powderject will provide new solutions in immunotheraputics.